Moreover, when stratifying CLL patients according to the karyotype prognosis value, we observed that the expression of ZHX1 and ZHX2 was significantly reduced in CLL patients presenting adverse karyotypes. The gene discussed is ZHX2; the disease is B-cell chronic lymphocytic leukemia.